Mengjiao Fan

Beijing, 100853, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Efficacy and safety of sintilimab plus bevacizumab and CAPOX as first-line treatment for patients with RAS-mutant, microsatellite stable, metastatic colorectal cancer.

Efficacy and safety of sintilimab plus bevacizumab and CAPOX as first-line treatment for patients with RAS-mutant, microsatellite stable, metastatic colorectal cancer.

Journal: BMC cancer

Published: September 26, 2024

Association between Dietary Vitamin E Intake and Human Papillomavirus Infection among US Adults: A Cross-Sectional Study from National Health and Nutrition Examination Survey.

Association between Dietary Vitamin E Intake and Human Papillomavirus Infection among US Adults: A Cross-Sectional Study from National Health and Nutrition Examination Survey.

Journal: Nutrients

Published: August 06, 2023

Functional identification and prediction of lncRNAs in esophageal cancer.

Functional identification and prediction of lncRNAs in esophageal cancer.

Journal: Computers in biology and medicine

Published: April 26, 2023

Immune function of colon cancer associated miRNA and target genes.

Immune function of colon cancer associated miRNA and target genes.

Journal: Frontiers in immunology

Published: April 10, 2023

A real-world analysis of second-line treatment option, gemcitabine plus anlotinib and anti-PD1, in advanced pancreatic cancer.

A real-world analysis of second-line treatment option, gemcitabine plus anlotinib and anti-PD1, in advanced pancreatic cancer.

Journal: Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]

Published: February 19, 2023

Survival outcome of different treatment sequences in patients with locally advanced and metastatic pancreatic cancer.

Survival outcome of different treatment sequences in patients with locally advanced and metastatic pancreatic cancer.

Journal: BMC cancer

Published: January 04, 2023

A composite indicator of derived neutrophil-lymphocyte ratio and lactate dehydrogenase correlates with outcomes in pancreatic carcinoma patients treated with PD-1 inhibitors.

A composite indicator of derived neutrophil-lymphocyte ratio and lactate dehydrogenase correlates with outcomes in pancreatic carcinoma patients treated with PD-1 inhibitors.

Journal: Frontiers in oncology

Published: May 24, 2022

FAM117A Is a New Prognostic Marker of Lung Adenocarcinoma and Predicts Sensitivity to PD0332991.

FAM117A Is a New Prognostic Marker of Lung Adenocarcinoma and Predicts Sensitivity to PD0332991.

Journal: Evidence-based complementary and alternative medicine : eCAM

Published: October 28, 2021

Response to olaparib in metastatic lung adenocarcinoma with germline BRCA2 mutation: a case report.

Response to olaparib in metastatic lung adenocarcinoma with germline BRCA2 mutation: a case report.

Journal: Anti-cancer drugs

Published: August 13, 2021

Hyperprogressive Disease Caused by PD-1 Inhibitors for the Treatment of Pan-Cancer.

Hyperprogressive Disease Caused by PD-1 Inhibitors for the Treatment of Pan-Cancer.

Journal: Disease markers

Published: November 30, 2020

Divergent expression of DCLK1 in gastrointestinal neuroendocrine tumors and primary hepatic, gallbladder, and pancreatic neuroendocrine tumors.

Divergent expression of DCLK1 in gastrointestinal neuroendocrine tumors and primary hepatic, gallbladder, and pancreatic neuroendocrine tumors.

Journal: International journal of clinical and experimental pathology

Published: May 20, 2020

Expression and prognostic significance of doublecortin-like kinase 1 in patients with hepatocellular carcinoma.

Expression and prognostic significance of doublecortin-like kinase 1 in patients with hepatocellular carcinoma.

Journal: Oncology letters

Published: July 04, 2016

Showing 1-12 of 12

Last Updated: 09/26/2026